In silico Molecular Docking and ADME Studies of 1,3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity

作者: Belgin Sever , Kaan Kucukoglu , Hayrunnisa Nadaroglu , Mehlika Dilek Altıntop

DOI: 10.2174/1573409914666180518085908

关键词: ParaoxonaseActive siteChemistryBiochemistryIn vitroADMEThio-In silicoPON1Molecular model

摘要: Background Paraoxonase 1 (PON1) is a paraoxonase, arylesterase and lactonase associated with protection of lipoproteins cell membranes against oxidative modification. Objective Based on antioxidative properties PON1 significance 1,3,4-thiadiazoles in pharmaceutical chemistry, herein we aimed to evaluate the potentials 1,3,4-thiadiazole derivatives as activators. Methods 2-[[5-(2,4-Difluoro/dichlorophenylamino)-1,3,4-thiadiazol-2-yl]thio]acetophenone (1-18) were vitro evaluated for their activator effects which was purified using ammonium sulfate precipitation (60-80%) DEAE-Sephadex anion exchange chromatography. Molecular docking studies performed detection affinities all compounds active site PON1. Moreover, Absorption, Distribution, Metabolism Excretion (ADME) also silico predicted. In molecular ADME carried out according modules Schrodinger's Maestro modeling package. Results All compounds, particularly 10, 13 17, determined promising activators apart from compound 1, them detected Besides, results indicated that potential orally bioavailable drug-like molecules. Conclusion activators, 17 stand drug candidates further antioxidant these can be investigated therapeutic many disorders such atherosclerosis, diabetes mellitus, obesity, chronic liver inflammation more.

参考文章(36)
Joanna Matysiak, Biological and pharmacological activities of 1,3,4-thiadiazole based compounds. Mini-reviews in Medicinal Chemistry. ,vol. 15, pp. 762- 775 ,(2015) , 10.2174/1389557515666150519104057
Edward C. Meek, Howard W. Chambers, Ronald B. Pringle, Janice E. Chambers, The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats. Toxicology. ,vol. 336, pp. 79- 83 ,(2015) , 10.1016/J.TOX.2015.08.002
Haci Ahmed Alici, Deniz Ekinci, Şükrü Beydemir, Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo Clinical Biochemistry. ,vol. 41, pp. 1384- 1390 ,(2008) , 10.1016/J.CLINBIOCHEM.2008.06.017
Michael Aviram, Jacob Vaya, Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. Current Opinion in Lipidology. ,vol. 24, pp. 339- 344 ,(2013) , 10.1097/MOL.0B013E32835FFCFD
Deniz Ekinci, Şükrü Beydemir, Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases. European Journal of Pharmacology. ,vol. 617, pp. 84- 89 ,(2009) , 10.1016/J.EJPHAR.2009.06.048
Hagai Tavori, Soliman Khatib, Michael Aviram, Jacob Vaya, Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity. Bioorganic & Medicinal Chemistry. ,vol. 16, pp. 7504- 7509 ,(2008) , 10.1016/J.BMC.2008.06.008
Gennaro Giordano, Toby B. Cole, Judit Marsillach, Clement E. Furlong, Lucio G. Costa, Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity Toxicology. ,vol. 307, pp. 115- 122 ,(2013) , 10.1016/J.TOX.2012.07.011